IFRX Total Utang marang Modal InflaRx
German biopharmaceutical developer InflaRx N.V. (IFRX) focuses on developing C5a antibodies for the therapy of severe inflammation and rare pathologies, currently conducting final clinical trials. This chart of share prices on GURU.Markets demonstrates a total debt-to-equity ratio of 0.01. The company's financial stability relies on current sales of treatments for viral complications and the upcoming launch of innovative drugs.
Rincian analitis lan laporan data perusahaan InflaRx (IFRX)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Analisis komprehensif perusahaan:IFRX - InflaRx N.V.
Within the biotechnology sector, InflaRx N.V. focuses on attracting Germany's leading immunologists, which requires sustainable funding for R&D processes. By analyzing the total liabilities-to-equity ratio, an investor assesses the proportion of borrowed funds within the balance sheet structure, where an increase in the metric indicates credit risks, while its minimum reflects conservative capital management to preserve scientific independence.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Total Utang marang Modal PVLA (Pieris Pharmaceuticals Inc)|SVRA: Koefisien Total Utang marang Modal|Utang marang Ekuitas Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Rasio Utang marang Ekuitas|Total Utang marang Modal Astria Therapeutics, Inc. ATXS|Utang Agregat marang Ekuitas ENGN|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|Utang marang Ekuitas aerovatetx.com (JBIO)|Total Utang marang Modal ACRS (Aclaris Therapeutics)|kyvernatx.com - Total Utang marang Modal|Utang marang Ekuitas Tiziana Life Sciences Ltd (TLSA)|Cabaletta Bio Inc. (CABA) - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas Ventyx Bio|Rasio Utang marang Ekuitas Theratechnologies, Inc|AVTX - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ELDN|Utang marang Ekuitas Agenus Inc. AGEN|Rasio Utang marang Ekuitas Climb Bio Inc. CLYM|Rasio Total Utang marang Ekuitas ZURA|ATYR - Koefisien Total Utang marang Modal|ADAG - Rasio Total Utang marang Ekuitas|ImageneBio Inc (IMA) - Utang marang Ekuitas|shattucklabs.com - Rasio Total Utang marang Ekuitas|Equillium (EQ) - Koefisien Total Utang marang Modal|CNTB: Total Utang marang Modal|Koefisien Total Utang marang Modal Immunic Inc|ATRA - Total Utang marang Modal|Utang Agregat marang Ekuitas XFOR (x4pharma.com)|Utang marang Ekuitas Adicet Bio, Inc.|CELU - Rasio Kabeh Utang marang Dana Pribadi|INmune Bio Corp (INMB) - Rasio Total Utang marang Ekuitas|BRNS: Rasio Utang marang Ekuitas|Utang marang Ekuitas Kezar Life Sciences (KZR)|sabbiotherapeutics.com (SABS) - Utang Agregat marang Ekuitas|AKTX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Enlivex Therapeutics, Ltd.|Total Utang marang Modal QTTB|Total Utang marang Modal GOVX (GeoVax Corp)|Utang marang Ekuitas Edesa Biotech, Inc.|ibioinc.com - Rasio Kabeh Utang marang Dana Pribadi|CARM: Utang marang Ekuitas|XTLB - Rasio Total Utang marang Ekuitas|BOLT: Total Utang marang Modal|Total Utang marang Modal HCW Biologics|APVO - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AIM ImmunoTech, Inc.|ADTX (Aditxt) - Total Utang marang Modal|Koefisien Total Utang marang Modal GRI (GRI Bio Inc)|XORTX - Utang marang Ekuitas|Vyome Therapeutics - Rasio Total Utang marang Ekuitas|REVB: Utang marang Ekuitas|indaptusrx.com (INDP) - Rasio Total Utang marang Ekuitas|SCNI: Rasio Total Utang marang Ekuitas|CALI (CalciMedica) - Total Utang marang Modal|Utang marang Ekuitas Affimed NV (AFMD)|Rasio Utang marang Ekuitas Allakos Therapeutics|HOOKIPA Pharma Inc. - Total Utang marang Modal|Utang marang Modal igmbio.com (IGMS)|Total Utang marang Modal ITOS|Ocean Biomedical Inc - Koefisien Total Utang marang Modal|TC BioPharm (Holdings) PLC (TCBP) - Utang marang Ekuitas|THRD - Rasio Utang marang Ekuitas